Atea Pharmaceuticals Q1 2026 Earnings Narrower Loss Beats Expectations Stock Edges Higher UTI Q1 2026 Earnings EPS Misses Estimates Stock Rises on Potential Optimism UHAL Q1 2026 Earnings Massive EPS Miss Sends Caution Signals BJRI Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Instil Bio Q1 2026 Earnings EPS Miss as DevelopmentStage Company Reports No Revenue Stock Edges Up WASH Q1 2026 Earnings Profit Misses Expectations as Stock Holds Steady